Caroline Litchfield - Apr 30, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP & CFO
Signature
/s/ Kelly E. W. Grez as attorney-in-fact for Caroline Litchfield
Stock symbol
MRK
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 04:07 PM
Previous filing
Feb 15, 2024
Next filing
Oct 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 50.9K Apr 30, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +49.8K $0.00 49.8K Apr 30, 2024 Common Stock 49.8K $129.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.